Pharmaceutical Companies Targeting Major Western Markets for New Drug Launches
September 14, 2016 08:08 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - September 14, 2016) - A recent study found that 74% of surveyed drug companies market new products in the US during their first launch wave. During this same...
Pharma Launch Sequencing Trends: Brand Team Involvement in Ad Hoc Committees
August 24, 2016 07:41 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - August 24, 2016) - Although pharmaceutical brand teams do not have the final say on their products' launch sequences, they play an active role in ad hoc...
Nine out of 10 Pharmas Wait Until Phase 3 to Complete Commercial Risk Assessment Activities
August 18, 2016 07:41 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - August 18, 2016) - The vast majority (88%) of surveyed pharmaceutical companies do not complete commercial risk assessment activities until Phase 3...
62% of C-Level Executives Dominate the Approval of Pharmaceutical Launch Sequences
June 17, 2016 08:38 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwired - June 17, 2016) - A new study published by Cutting Edge Information found that 50% of Top 10 and Top 50 firms turn to C-level executives when planning launch...
Pharma Business Development Teams Must Focus on Strategic Fit Rather Than Name Game
July 12, 2011 09:47 ET
|
Cutting Edge Information
RESEARCH TRIANGLE PARK, NC--(Marketwire - Jul 12, 2011) - When pharmaceutical and biotechnology companies select a partner for a licensing deal, there is a strong temptation to go for the biggest...